NATCO Pharma Balance Sheet Health
Financial Health criteria checks 6/6
NATCO Pharma has a total shareholder equity of ₹52.9B and total debt of ₹2.5B, which brings its debt-to-equity ratio to 4.7%. Its total assets and total liabilities are ₹62.5B and ₹9.6B respectively. NATCO Pharma's EBIT is ₹14.6B making its interest coverage ratio -35.9. It has cash and short-term investments of ₹12.2B.
Key information
4.7%
Debt to equity ratio
₹2.48b
Debt
Interest coverage ratio | -35.9x |
Cash | ₹12.16b |
Equity | ₹52.94b |
Total liabilities | ₹9.61b |
Total assets | ₹62.54b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524816's short term assets (₹33.5B) exceed its short term liabilities (₹8.8B).
Long Term Liabilities: 524816's short term assets (₹33.5B) exceed its long term liabilities (₹822.0M).
Debt to Equity History and Analysis
Debt Level: 524816 has more cash than its total debt.
Reducing Debt: 524816's debt to equity ratio has reduced from 6.5% to 4.7% over the past 5 years.
Debt Coverage: 524816's debt is well covered by operating cash flow (302.1%).
Interest Coverage: 524816 earns more interest than it pays, so coverage of interest payments is not a concern.